The 10th RSC-BMCS Fragment-based Drug Discovery (FBDD) Meeting is less than one week away, and Life Chemicals looks forward to meeting researchers working in fragment screening, hit discovery, medicinal chemistry and structure-based drug discovery.
The event will be a good opportunity for its participants to discover our specialized Fragment Libraries for FBDD, including collections designed around:
- 3D shape and Fsp³ enrichment
- Solubility and diversity
- Covalent and PPI discovery
- Fluorine and halogen chemistry
- Natural product-like and low-MW fragments
- Chelators and ADMET-relevant fragments
- Specialized FBDD and DSI-poised collections
The libraries we are going to present provide a broad chemical diversity while facilitating practical downstream medicinal chemistry and hit-to-lead workflows.
The RSC-BMCS meeting is a promising platform to discuss the latest developments in fragment-based drug discovery, focusing on fragment-screening technologies, hit validation, structural biology and the progression of fragment-derived hits into advanced drug discovery programmes.
Interested in supporting your next FBDD project? Our representative, Dr. Anna Zaitseva, will be happy to offer various approaches to make your projects a success. Welcome to Booth # 14!
Contact information:
Anna Zaitseva, PhD
Director of Business Development
Life Chemicals Europe GmbH
Anna.Zaitseva@lifechemicals.com
Fragments26 | Booth #14 | Cambridge | September 14-16